Identification and engineering of antibodies with variant FC regions and methods of using same

Details for Australian Patent Application No. 2006279945 (hide)

Owner Macrogenics, Inc.

Inventors Tuaillon, Nadine; Rankin, Christopher; Stavenhagen, Jeffery; Gorlatov, Sergey

Agent Fisher Adams Kelly

Pub. Number AU-B-2006279945

PCT Pub. Number WO2007/021841

Priority 60/707,419 10.08.05 US

Filing date 10 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 12 April 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/00 (2006.01) Mutation or genetic engineering

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/021841 Priority application(s): WO2007/021841

12 April 2012 Application Accepted

  Published as AU-B-2006279945

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279949-Fill port for a self-priming centrifugal pump, with safety device

2006279943-Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysinespecific demethylase inhibitors